Sign in

CIK 0000876343

  • Non-accelerated filer
  • Smaller reporting company

Lineage Cell Therapeutics, Inc.

Sign in to watch
Ticker
LCTX
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
943127919
Phone
+1 510-521-3390
Business address
2173 SALK AVENUE, SUITE 200, CARLSBAD, CA, 92008
Former names
BIOTIME INC
  1. 4 Open-market buy President and CEO bought 5,250 shares at $1.38 ($7,245)
  2. 4 Open-market buy Director bought 930,106 shares at an average $1.42 ($1,317,667)
  3. 4 Open-market buy Director bought 7,000 shares at $1.40 ($9,800)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 5 Insider Annual Insider Trading Report
  13. 4 Shares withheld for taxes President and CEO gave up 5,343 shares (to pay taxes)
  14. 4 Open-market sale SVP,Clinical & Medical Affairs sold 539,283 shares at an average $2.45 ($1,321,329)
  15. 4 Shares withheld for taxes President and CEO gave up 5,343 shares (to pay taxes)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 5 of 36 · 720 filings